John W. Elling
Director Ejecutivo en GPER G-1 Development Group LLC .
Cargos activos de John W. Elling
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Vista Therapeutics, Inc.
Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | Director/Miembro de la Junta | 13/06/2011 | - |
GPER G-1 Development Group LLC
GPER G-1 Development Group LLC Pharmaceuticals: MajorHealth Technology GPER G-1 Development Group LLC is a company that has developed a novel therapeutic called G-1 (Tespria) for the treatment of diabetes and obesity. Approximately one third of the population is either diabetic or pre-diabetic, and the estimated economic burden of diabetes in the US in 2017 was over $300 billion. The company is based in Albuquerque, NM. The company aims to target metabolic activity in "brown fat" cells to treat these conditions. G-1 (Tespria) has minimal competition and is revolutionary in that it modulates energy expenditure in the absence of changes in food intake or activity. The company was founded by John J. Chavez, and the CEO is John W. Elling. | Director Ejecutivo | - | - |
Historial de carrera de John W. Elling
Antiguos cargos conocidos de John W. Elling.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Director Ejecutivo | 01/11/2005 | 10/06/2011 |
Presidente | 19/08/2009 | 10/06/2011 | |
Fundador | 01/11/2005 | 10/06/2011 | |
Presidente | 01/11/2005 | 19/08/2009 | |
Greffen Systems, Inc.
Greffen Systems, Inc. Industrial MachineryProducer Manufacturing Greffen Systems, Inc. provides HVAC industrial solutions. It offers design, project management, installation, testing and ongoing product services. The firm specializes in UV-C germicidal lighting, upper air fixtures, M2G and infection control solution. The company was founded in 2008 and is headquartered in Dawsonville, GA. | Director Ejecutivo | - | - |
Presidente | - | - | |
Fundador | - | - | |
Presidente | - | - | |
MESA Technology, Inc. | Director Ejecutivo | - | - |
Fundador | - | - | |
Presidente | - | - | |
Nicolet Instrument Corp. | Corporate Officer/Principal | - | - |
Mitotech LLC
Mitotech LLC Pharmaceuticals: MajorHealth Technology Mitotech LLC develops medical nanotechnology solutions. The firm's pipeline has a number of drug candidates based on mitochondria-addressed antioxidant. Its specialties include nanobiotechnology, drug development, research and development in biology and medicine. The company was founded by Maxim Skulachev and John W. Elling in 2009 and is headquartered in Moscow, Russia. | Director Ejecutivo | - | - |
Fundador | - | - | |
Presidente | - | - | |
xF Technologies, Inc.
xF Technologies, Inc. Chemicals: SpecialtyProcess Industries xF Technologies, Inc. engages as a technology development company which produces non-toxic specialty chemicals. Its chemical applications include cleaning and processing solvents, plasticizers, coalescents , and personal care. The company was founded by Jacob Berman and Aviad Cahana in January 2007 and is headquartered in Moriarty, NM. | Director Ejecutivo | - | - |
Presidente | - | - | |
IG Assets, Inc.
IG Assets, Inc. Miscellaneous Commercial ServicesCommercial Services IG Assets products and services are based on ERGO, its web-based genome analysis platform. ERGO integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO provides better and faster identification of gene function across all organisms. Its scientists have broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. | Director Ejecutivo | 13/06/2011 | - |
░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | - | - |
Formación de John W. Elling.
University of Wisconsin | Doctorate Degree |
Anderson School of Management | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 15 |
Rusia | 2 |
Operativa
Chief Executive Officer | 10 |
President | 8 |
Founder | 7 |
Sectorial
Health Technology | 6 |
Commercial Services | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 13 |
---|---|
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Commercial Services |
Bioreason, Inc.
Bioreason, Inc. Packaged SoftwareTechnology Services Bioreason, Inc. was engaged in developing enterprise software. The company was headquartered in Santa Fe, NM. | Technology Services |
Cytoprint, Inc.
Cytoprint, Inc. Medical SpecialtiesHealth Technology Cytoprint, Inc. develops proprietary image classification technology for fluorescence cellular microscopy. Its technology focuses on discovery assays for important biological processes and on linking biological processes to gene and protein function. The company was founded by John W. Elling and Christopher B. Shumate in 2001 and is headquartered in Santa Fe, NM. | Health Technology |
Los Alamos National Laboratory
Los Alamos National Laboratory Miscellaneous Commercial ServicesCommercial Services Los Alamos National Laboratory operates as a multidisciplinary institution. It offers services in science, engineering, earth science, chemistry, mathematics, physics, and space science. The company was founded in 1943 and is headquartered in Los Alamos, NM. | Commercial Services |
Acoustic Cytometry Systems, Inc.
Acoustic Cytometry Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Acoustic Cytometry Systems, Inc. manufactures cell-testing devices. It commercializes single molecule sensitivity flow cytometers that enable a new generation of proprietary applications in life science research, clinical diagnostics, and industry. The company's products are used for blood exam and medical research. Acoustic Cytometry Systems was founded by John W. Elling in 2006 and is headquartered in Los Alamos, NM | Electronic Technology |
IG Assets, Inc.
IG Assets, Inc. Miscellaneous Commercial ServicesCommercial Services IG Assets products and services are based on ERGO, its web-based genome analysis platform. ERGO integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO provides better and faster identification of gene function across all organisms. Its scientists have broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. | Commercial Services |
Vista Therapeutics, Inc.
Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | Health Technology |
xF Technologies, Inc.
xF Technologies, Inc. Chemicals: SpecialtyProcess Industries xF Technologies, Inc. engages as a technology development company which produces non-toxic specialty chemicals. Its chemical applications include cleaning and processing solvents, plasticizers, coalescents , and personal care. The company was founded by Jacob Berman and Aviad Cahana in January 2007 and is headquartered in Moriarty, NM. | Process Industries |
Mitotech LLC
Mitotech LLC Pharmaceuticals: MajorHealth Technology Mitotech LLC develops medical nanotechnology solutions. The firm's pipeline has a number of drug candidates based on mitochondria-addressed antioxidant. Its specialties include nanobiotechnology, drug development, research and development in biology and medicine. The company was founded by Maxim Skulachev and John W. Elling in 2009 and is headquartered in Moscow, Russia. | Health Technology |
Nicolet Instrument Corp. | Health Technology |
MESA Technology, Inc. | Technology Services |
Greffen Systems, Inc.
Greffen Systems, Inc. Industrial MachineryProducer Manufacturing Greffen Systems, Inc. provides HVAC industrial solutions. It offers design, project management, installation, testing and ongoing product services. The firm specializes in UV-C germicidal lighting, upper air fixtures, M2G and infection control solution. The company was founded in 2008 and is headquartered in Dawsonville, GA. | Producer Manufacturing |
GPER G-1 Development Group LLC
GPER G-1 Development Group LLC Pharmaceuticals: MajorHealth Technology GPER G-1 Development Group LLC is a company that has developed a novel therapeutic called G-1 (Tespria) for the treatment of diabetes and obesity. Approximately one third of the population is either diabetic or pre-diabetic, and the estimated economic burden of diabetes in the US in 2017 was over $300 billion. The company is based in Albuquerque, NM. The company aims to target metabolic activity in "brown fat" cells to treat these conditions. G-1 (Tespria) has minimal competition and is revolutionary in that it modulates energy expenditure in the absence of changes in food intake or activity. The company was founded by John J. Chavez, and the CEO is John W. Elling. | Health Technology |
- Bolsa de valores
- Insiders
- John W. Elling
- Experiencia